Media & Events

Our participation in various global symposiums and events, gives us an opportunity to showcase to the world the entire gammut of products we offer. At Transasia Bio-Medicals Ltd., we encourage regular interactions with our business associates and partners, through seminars and conferences.
News Updates
3 APR 2011 Transasia announces new partnership and launch of new products in India!-
Transasia announces new partnership and launch of new products in India!-
Transasia has signed an exclusive Marketing agreement with Vircell Microbiologists, Spain for marketing its ready-to-use kits for the diagnosis of infectious diseases using ELISA, IFA, Rapids and Agglutination techniques.

Under this agreement, Transasia will exclusively market kits for Infectious diseases likePneumonia, Brucellosis, Dengue, Infectious Mononucleosis and many more. Customized products and services will be evaluated by both management teams to maximize benefits to the Indian patients.

Vircell is a microbiology company with global presence in the market. Its international focus can be seen in the worldwide presence of its products, in laboratories of more than 60 countries.  All its activities are ISO certified and its Clinical Diagnostic reagents are CE marked.

Vircell’s scientific outlook and orientation on quality converges very well with Transasia’s single minded focus on customer satisfaction, right from product conception to after-sales service.

The official launch was announced on 3rd April 2011 at a Scientific Session on “Pneumonia – Trends in Diagnosis” organized by Transasia Bio-Medicals Ltd. in Mumbai. Renowned Chest physician - Dr. Zarir F Udwadia from Hinduja Hospital, Mumbai elaborated on Community acquiredPneumonia in India and Dr. Jose Rojas, R&D Director and Head of the Department of Immunology at Vircell provided technical insights on pneumonia diagnosis and introduced Vircell’s complete solutions in this field. This seminar was attended by the most respected pathologists, microbiologists and chest physicians in Mumbai.

Both, Transasia and Vircell believe in developing innovative products, bringing significant advances to the IVD market. This new basket of wide spectrum Infectious Disease products from Transasia is definitely an added advantage which will benefit Indian customers due to high quality at affordable prices.